Natalja Eigeliene

Clinical Oncology (Department of Clinical Medicine)

nateig@utu.fi

Kiinamyllynkatu 10

Turku

Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT (2022)
- Radiation Oncology
Karagiannis Vasileios, Wichmann Viktor, Saarinen Juha, Eigeliene Natalja, Andersen Heidi, Jekunen Antti
Real-World, Retrospective Data of Pancreatic Cancer Treatment Outcomes (2022)
- Pancreas
Vikström Jacob, Shangin Georgii, Viitanen Tommi, Eigeliene Natalja, Jekunen Antti
Current challenges in applying gene-driven therapies in clinical lung cancer practice (2021)
- World Journal of Clinical Oncology
Saarenheimo Jatta, Andersen Heidi, Eigeliene Natalja, Jekunen Antti P.
Gene-Guided Treatment Decision-Making in Non-Small Cell Lung Cancer - A Systematic Review (2021)
- Frontiers in Oncology
Saarenheimo Jatta, Andersen Heidi, Eigeliene Natalja, Jekunen Antti
Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment (2021)
- Case Reports in Oncology
Eigeliene Natalja, Saarenheimo Jatta, Wichmann Viktor, Österlund Pia, Jekunen Antti
Preemptive screening of DPYD as part of clinical practice: high prevalence of a novel exon 4 deletion in the Finnish population (2021)
- Cancer Chemotherapy and Pharmacology
Saarenheimo Jatta, Wahid Nesna, Eigeliene Natalja, Ravi Ravichandra, Salomons Gajja S., Ojeda Matilde Fernandez, Vijzelaar Raymon, Jekunen Antti, van Kuilenburg André B. P.
Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures (2020)
- Cellular Oncology
Kähkönen TE, Toriseva M, Petruk N, Virta AR, Maher A, Eigeliene N, Kaivola J, Boström P, Koskivuo I, Nees M, Tuomela JM, Ivaska KK, Härkönen PL
The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer (2019)
- Frontiers in Oncology
Saarenheimo J, Eigeliene N, Andersen H, Tiirola M, Jekunen A
Human Metaplastic Breast Carcinoma and Decorin (2017)
- Cancer Microenvironment
Boström P, Sainio A, Eigėlienė N, Jokilammi A, Elenius K, Koskivuo I, Järveläinen H
Comparison of the Effects of the Selective Estrogen Receptor Modulators Ospemifene, Raloxifene, and Tamoxifen on Breast Tissue in Ex Vivo Culture (2016) Estrogen Receptors Natalija Eigeliene, Risto Erkkola, Pirkko Härkönen
Effects of ospemifene, a novel selective estrogen-receptor modulator, on human breast tissue ex vivo (2016)
- Menopause
Eigeliene N, Kangas L, Hellmer C, Kauko T, Erkkola R, Härkönen P
Effects of Ospemifene on Breast Tissue Morphology and Proliferation: A Comparative Study Versus Other Selective Estrogen Receptor Modulators in Ovariectomized Rats (2014)
- Hormone and Metabolic Research
Kangas L, Harkonen P, Vaananen K, Keskitalo J, Eigeliene N
The Effects of Estradiol, Androgens and the Selective Estrogen Modulators: Ospemifene, Raloxifene and Tamoxifen on Explant Cultures of Human Breast Tissue
(2013) Eigeliene Natalija
Androgens inhibit the stimulatory action of 17β-estradiol on normal human breast tissue in explant cultures (2012)
- Journal of Clinical Endocrinology and Metabolism
Eigéliené Natalija, Elo Teresa, Linhala Mari, Hurme Saija, Erkkola Risto, Härkönen Pirkko
Placental abruption: etiology, clinical manifestation and management (2010) Eigeliene N, Maleckiene L
Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures (2006)
- BMC Cancer
Natalija Eigeliene, Pirkko Härkönen, Risto Erkkola